Risk factors, prevention, and treatment of corticosteroid-induced osteoporosis in adults.
An orthopedist can play a critical role in corticosteroid induced osteoporosis management by identifying at-risk patients and selecting appropriate prophylactic measures. This article is part two in a two-part series on osteoporosis. Part one appeared in the July 2008 issue of ORTHOPEDICS.
Ruf
Kathryn M
KM
University of Kentucky, College of Pharmacy, Lexington 40536-0293, USA.
Johnson
Nicole K
NK
Clifford
Timothy
T
Smith
Kelly M
KM
D000328:Adult; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D002116:Calcitonin / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008019:Life Style; D010024:Osteoporosis / Q000139:chemically induced* / Q000503:physiopathology / Q000517:prevention & control*; D010281:Parathyroid Hormone / Q000627:therapeutic use; D012307:Risk Factors
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D005938:Glucocorticoids; D010281:Parathyroid Hormone; D002116:Calcitonin